New Zealand markets closed
  • NZX 50

    -37.69 (-0.34%)

    +0.0055 (+0.85%)

    +0.0048 (+0.80%)

    +73.80 (+1.01%)
  • ASX 200

    +76.80 (+1.08%)
  • OIL

    +0.98 (+0.86%)
  • GOLD

    +3.00 (+0.16%)

    +404.63 (+3.30%)
  • FTSE

    +20.54 (+0.27%)
  • Dow Jones

    +575.77 (+1.76%)
  • DAX

    +230.90 (+1.62%)
  • Hang Seng

    +581.16 (+2.89%)
  • NIKKEI 225

    +176.84 (+0.66%)

    +0.7640 (+0.93%)

Insights on the Biopharmaceutical Excipients Global Market to 2026 - Featuring Ashland, BASF and Clariant Among Others -

·4-min read

DUBLIN, January 07, 2022--(BUSINESS WIRE)--The "Biopharmaceutical Excipients Market Research Report by Product, by Function, by Application, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19" report has been added to's offering.

The Global Biopharmaceutical Excipients Market size was estimated at USD 188.70 million in 2020 and expected to reach USD 227.78 million in 2021, at a CAGR 21.04% to reach USD 593.66 million by 2026.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Biopharmaceutical Excipients Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Biopharmaceutical Excipients Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Biopharmaceutical Excipients Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Biopharmaceutical Excipients Market?

4. What is the competitive strategic window for opportunities in the Global Biopharmaceutical Excipients Market?

5. What are the technology trends and regulatory frameworks in the Global Biopharmaceutical Excipients Market?

6. What is the market share of the leading vendors in the Global Biopharmaceutical Excipients Market?

7. What modes and strategic moves are considered suitable for entering the Global Biopharmaceutical Excipients Market?

Market Dynamics


  • Rising demand over better functionality and cutting-edge drug formulations

  • Rise in the need for large molecule development

  • Increasing development of Biosimilars


  • High price of market product


  • Outsourcing of biologics manufacturing to emerge as a major trend

  • Substantial rise in need of functional excipients in recent years


  • Formulation challenges for biopharmaceuticals development

Companies Mentioned

  • ABITEC Corporation

  • Ashland Inc.

  • Associated British Foods PLC


  • Clariant AG

  • Colorcon, Inc.

  • DFE Pharma

  • Dow Chemical Company

  • Evonik Industries AG

  • Fuji Chemical Industries Co., Ltd.

  • IMCD

  • Innophos Holdings Inc.,



  • Meggle AG

  • Merck KGaA

  • Merck Millipore

  • Pharmonix Biological Pvt. Ltd

  • Roquette Freres

  • Sigachi Industries Pvt. Ltd.

  • Spectrum Chemical Manufacturing Corp.

  • SPI Pharma

  • The Lubrizol Corporation

  • Wacker Chemie AG

For more information about this report visit

View source version on

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting